Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Stereotaxis Receives Commitment to Increase and Extend Credit Facility

November 10, 2010 4:34 pm | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Nov. 10, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that the Company has received a commitment letter from Silicon Valley Bank for an amended credit agreement that extends its revolving $30 million credit facility to March 31, 2012.  Consistent with the...

TOPICS:

Stereotaxis amends $30 million in credit(4)

November 10, 2010 3:46 pm | by The Associated Press | News | Comments

Stereotaxis Inc. said Wednesday that it received a commitment letter from Silicon Valley Bank for an amended credit agreement that extends its revolving $30 million credit facility to March 31, 2012.The revolving line of credit commitment includes a sublimit of $10 million for advances guaranteed...

Next Generation Power Packages for Implantables

November 10, 2010 11:12 am | by Tom Zemites | Articles | Comments

When it comes to implantable medical devices, space savings is one of the most critical design concerns. This article reviews packaging concepts available to reduce the space required by electronic power components so that the overall implant can shrink and/or more features can be added without enlargement.

Advertisement

Researchers unlock how key drug kills tropical parasites

November 10, 2010 10:35 am | by EurekAlert | News | Comments

(Michigan State University) In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and...

TOPICS:

Inhibitory neurons key to understanding neuropsychiatric disorders

November 10, 2010 10:33 am | by Baylor College of Medicine | News | Comments

The brain works because 100 billion of its special nerve cells called neurons regulate trillions of connections that carry and process information. The behavior of each neuron is precisely determined by the proper function of many genes. In 1999, Baylor College of Medicine researcher Dr....

TOPICS:

Data Analysis Helps Reduce Product Failures

November 10, 2010 10:06 am | by Andrew Lux, Ph.D. | Articles | Comments

One of the critical goals of a medical device manufacturing project is to eliminate the occurrence of product failure. While there are a number of methodologies to implement in order to help increase the chances of success, this article highlights one technique that relies on multi-variate data analysis to achieve the goal.

Class I Medical Device Recall: bioM & #xe9;rieux, Inc., VITEK 2 Gram Negative Susceptibility Cards Containing Piperacillin/Tazobactam (TZP)

November 10, 2010 8:37 am | by U.S. Food & Drug Administration | News | Comments

VITEK 2 Gram Negative Susceptibility Cards that contain Piperacillin/Tazobactam are reporting incorrect results for testing the susceptibility of E. coli and K. pneumoniae to this drug.

ULURU Inc. Provides Altrazeal® Clinical Update

November 10, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

ADDISON, Texas, Nov. 10, 2010 /- ULURU Inc. (NYSE Amex: ULU ) today provided a clinical update and summary of recent participation at major wound care conferences. During the past 45 days Altrazeal® has been presented at three major wound care conferences Symposium of Advanced Wound...

TOPICS:
Advertisement

Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference

November 10, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference -- JERUSALEM, November 10, 2010 /-...

TOPICS:

AACR Praises the U.S. Department of Health and Human Services for its Tobacco Prevention Efforts

November 10, 2010 8:34 am | by AACR | News | Comments

PHILADELPHIA — The American Association for Cancer Research applauds the U.S. Department of Health and Human Services (HHS) for its newly launched comprehensive tobacco control program.

TOPICS:

Obesity and Diabetes Are Increasing in Cats

November 10, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

ST. JOSEPH, Mo., Nov. 10, 2010 /- Diabetes isn’t just a human disease. This November – American Diabetes Month® – pet owners should know that the feline members of their families could suffer from the condition, too. Type 2 diabetes is the most common form in the...

TOPICS:

China Cord Blood Corporation Commences Warrant Exchange Offer

November 10, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO ) ("CCBC" or "the Company"), the first and largest cord blood bank operator in China, today commenced its previously announced warrant exchange offer, and provided warrant holders with...

TOPICS:

SIGVARIS Provides 'Red Socks' to Honor Efforts by Boston Red Sox Manager, Terry Francona, to Raise Awareness for DVT Prevention

November 10, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

PEACHTREE CITY, Ga., Nov. 10, 2010 /- SIGVARIS, the global leader in medical compression therapy, has teamed up with the North American Thrombosis Forum and Boston Red Sox Manager and blood clot survivor, Terry Francona, to raise awareness about the dangers of blood clots. Did you know...

TOPICS:

Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair

November 10, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

RICHMOND, Va., Nov. 10, 2010 /- Filtrona Porous Technologies, a custom developer and manufacturer of medical grade foam and fiber components designed to absorb, retain, transfer, filter or release fluids or vapors, will display an expanded range of polyurethane foams and bonded fibers at...

TOPICS:

China Medical test approved in China

November 10, 2010 6:45 am | by The Associated Press | News | Comments

China Medical Technologies Inc. said Wednesday that it received Chinese regulatory approval for its genetic test aimed at improving the targeted use of lung cancer drugs.The company said the State Food and Drug Administration of China approved the PCR-based Epidermal Growth Factor Receptor...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading